9-98807699-A-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PVS1_ModerateBS2

The NM_024642.5(GALNT12):​c.1A>C​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,145,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

GALNT12
NM_024642.5 initiator_codon

Scores

5
3
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.464

Publications

1 publications found
Variant links:
Genes affected
GALNT12 (HGNC:19877): (polypeptide N-acetylgalactosaminyltransferase 12) This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011]
GALNT12 Gene-Disease associations (from GenCC):
  • colorectal cancer, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 2 pathogenic variants. Next in-frame start position is after 65 codons. Genomic position: 98807891. Lost 0.111 part of the original CDS.
BS2
High AC in GnomAdExome4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALNT12NM_024642.5 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 10 ENST00000375011.4 NP_078918.3 Q8IXK2-1
LOC124902229XR_007061689.1 linkn.-119T>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALNT12ENST00000375011.4 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 10 1 NM_024642.5 ENSP00000364150.3 Q8IXK2-1
ENSG00000285706ENST00000647710.1 linkn.-135T>G upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0000133
AC:
2
AN:
150564
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000100
AC:
10
AN:
995228
Hom.:
0
Cov.:
30
AF XY:
0.0000147
AC XY:
7
AN XY:
475612
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
19344
American (AMR)
AF:
0.00
AC:
0
AN:
5592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
9992
East Asian (EAS)
AF:
0.00
AC:
0
AN:
15214
South Asian (SAS)
AF:
0.00
AC:
0
AN:
25148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
14102
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2384
European-Non Finnish (NFE)
AF:
0.0000115
AC:
10
AN:
867044
Other (OTH)
AF:
0.00
AC:
0
AN:
36408
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000133
AC:
2
AN:
150564
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
73510
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41164
American (AMR)
AF:
0.00
AC:
0
AN:
15140
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10010
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000296
AC:
2
AN:
67562
Other (OTH)
AF:
0.00
AC:
0
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 29, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has not been reported in the literature in individuals with GALNT12-related conditions. ClinVar contains an entry for this variant (Variation ID: 820494). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that disruption of the initiator codon affects GALNT12 protein function (PMID: 19617566). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change affects the initiator methionine of the GALNT12 mRNA. The next in-frame methionine is located at codon 65. -

not specified Uncertain:1
Nov 22, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M1? variant (also known as c.1A>C) is located in coding exon 1 of the GALNT12 gene and results from an A to C substitution at nucleotide position 1.This alters the methionine residue at the initiation codon (ATG). The c.1A>C alteration is expected to modify the initiation codon (ATG) resulting in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. -

Colorectal cancer, susceptibility to, 1 Uncertain:1
Mar 28, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Uncertain
0.10
CADD
Benign
18
DANN
Benign
0.84
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.50
N
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.97
D
MetaRNN
Pathogenic
0.81
D
MetaSVM
Benign
-1.0
T
PhyloP100
0.46
PROVEAN
Benign
-0.070
N
REVEL
Uncertain
0.30
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.055
B
Vest4
0.78
MutPred
0.61
Loss of loop (P = 0.1258);
MVP
0.32
ClinPred
0.97
D
GERP RS
3.3
PromoterAI
0.046
Neutral
Varity_R
0.90
gMVP
0.49
Mutation Taster
=18/182
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1259048855; hg19: chr9-101569981; API